Interview with Makoto Tahara, MD, PhD | Japan - Prova Education

Interview with Makoto Tahara, MD, PhD | Japan

Interview with Makoto Tahara, MD, PhD | Japan

10

10

Overview
While at the 2015 ECC conference in Vienna, Austria, Dr. Makoto Tahara spoke with us about what he thought were the best presentations and posters from the conference, and what was emerging in induction therapy and maintenance in head and neck cancer. We also discussed what is on the horizon for biomarkers and treating HPV and non-HPV related cancers of the head and neck.

Facebook Comments

Recommended

- Lyudmila Bazhenova, MD
  Peer
- Benjamin Levy, MD
  Peer
6
CME/CE
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
- Mark Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
4
CME/CE
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
0.25 credits
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunothera…
0.25 credits
- Mark Socinski, MD
  Peer
- Benjamin Levy, MD
  Peer
1
CME/CE
Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC
Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC
0.25 credits
Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC
0.25 credits
- Mark Socinski, MD
  Peer
- John V. Heymach, MD, PhD
  Peer
3
CME/CE
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC
0.25 credits
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-…
0.25 credits